Skip to main content
Clinical Trials/NCT02919709
NCT02919709
Unknown
Not Applicable

Follow up of Patients With Aortic Aneurysm by Dosage of Circulant Endothelial Progenitor Cells

Centre Hospitalier Universitaire de Besancon1 site in 1 country40 target enrollmentNovember 2013

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Thoracic or Abdominal Aortic Aneurysm With no Indication for Surgical Treatment
Sponsor
Centre Hospitalier Universitaire de Besancon
Enrollment
40
Locations
1
Primary Endpoint
progenitor cells CD34+ blood levels
Last Updated
7 years ago

Overview

Brief Summary

The study aims to investigate the existence of a reliable correlation between the progression of aortic diameters and blood levels of circulant endothelial progenitor cells CD34+ in patients with not surgical aortic aneurysms.

Registry
clinicaltrials.gov
Start Date
November 2013
End Date
November 2018
Last Updated
7 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Patients aged 18 or more.
  • Patients diagnosed with a thoracic or abdominal aortic aneurysm with no indication for surgical treatment (diameters \> 30 mm but \< 50 mm).
  • Patients accepting to sign a specific informed consent.

Exclusion Criteria

  • Unstable coronary artery disease.
  • Congenital heart disease.
  • Any evolving infectious syndrome or viral infection (HIV, HBV or HCV).
  • Any chronic inflammatory or autoimmune disease.
  • Prior administration of G-CSF; EPO; GM-CSF.
  • Liver failure.
  • Prior oncologic disease or ongoing cancer with a life expectancy \< 1 year.
  • Patients aged \< 18.

Outcomes

Primary Outcomes

progenitor cells CD34+ blood levels

Time Frame: 24 month after diagnosis

Study Sites (1)

Loading locations...

Similar Trials